Paroxetine exposure during pregnancy and the risk of cardiac malformations: What is the evidence?

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 88, Issue 3, 2010, Pages 171-174

  Bérard, Anick ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

CONGENITAL HEART MALFORMATION; FIRST TRIMESTER PREGNANCY; HEART ATRIUM SEPTUM DEFECT; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; NOTE; PHARMACOEPIDEMIOLOGY; PREGNANCY; PRENATAL DRUG EXPOSURE; PREVALENCE; PRIORITY JOURNAL; SAMPLE SIZE; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ADULT; DATA INTERPRETATION, STATISTICAL; EVIDENCE-BASED MEDICINE; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; META-ANALYSIS AS TOPIC; PAROXETINE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; SEROTONIN UPTAKE INHIBITORS; UNCERTAINTY;

EID: 77749292367     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20643     Document Type: Note

References (18)

1. Alwan S, Reefhuis J, Rasmussen SA, et al. 2007. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. NEJM 356:2684-2692.
2. Bérard A, Ramos E, Rey E, et al. 2007. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Birth Defects Res B Dev Reprod Toxicol 80:18-27.
3. Bradford-Hill A. 1965. The environment and disease: association or causation? Proc R Soc Med 58:295-300.
4. Buznikov GA, Lambert HW, Lauder JM. 2001. Serotonin and serotonin-like substances as regulators of early embryogenesis and morphogenesis. Cell Tissue Res 305:177-186.
5. Choi DS, Kellermann O, Richard S, et al. 1998. Mouse 5-HT2B receptor-mediated serotonin trophic functions. Ann N Y Acad Sci 861:67-73.
6. FDA. 2005. Advising of risk of birth defects with Paxil. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2005/ucm108527.htm. Accessed August 2nd 2009.
7. Gentile S, Bellantuono C. 2009. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine. J Clin Psychiatry 70:414-422.
8. Källén BA, Otterblad OP. 2007. Maternal use of selective serotonin reuptake inhibitors in early pregnancy and infant congenital malformation. Birth Defects Res A Clin Mol Teratol 79:301-308.
9. Louik C, Lin AE, Werler MM, et al. 2007. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. New Engl J Med 356:2675-2683.
10. Olesen C, Steffensen FH, Nielsen GL, et al. 1999. Drug use in first pregnancy and lactation: a population-based survey among Danish women. Eur J Clin Pharmacol 55:139-144.
11. Ramos E, Oraichi D, Rey E, et al. 2007. Prevalence and predictors of antidepressant use in a cohort of pregnant women. British Journal of Obstetics and Gynecology 114:1055-1064.
12. Sari Y, Zhou FC. 2003. Serotonin and its transporter on proliferation of fetal heart cells. Int J Dev Neurosci 21:417-424.
13. Schneeweiss S. 2006. Sensitivity analysis and external adjustment for unmeasured confounders in peidemiologic database studies of therapeutics. Pharmacoepidemiol Drug Saf 15:291-303.
14. Shuey DL, Sadler TW, Tamir H, Lauder JM. 1993. Serotonin and morphogenesis: transient expression of serotonin uptake and binding protein during craniofacial morphogenesis in the mouse. Anat Embryol (Berl) 187:75-85.
15. Sloot WN, Bowden HC, Yih TD. 2009. In vitro and in vivo reproduction toxicology of 12 monoaminergic reuptake inhibitors: possible mechanisms of infrequent cardiovascular anomalies. Reprod Toxicol 28: 270-282.
16. Webster WS, Friedman JA. 2003. Prescription drugs and pregnancy. Expert Opin Pharmacother 4:949-961.
17. Wurst K, Poole C, Ephross S, Olshan A. 2009. First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiologic studies. Birth Defects Res A Clin Mol Teratol xx:xxx-xxx
18. Yavarone MS, Shuey DL, Tamir H, et al. 1993. Serotonin and cardiac morphogenesis in the mouse embryo. Teratology 47:573-584.